<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="158164">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02026193</url>
  </required_header>
  <id_info>
    <org_study_id>RMB-0439-13</org_study_id>
    <nct_id>NCT02026193</nct_id>
  </id_info>
  <brief_title>IVF Hyper-responders: Oocyte Vitrification Compared With Embryo Freezing</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rambam Health Care Campus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rambam Health Care Campus</source>
  <oversight_info>
    <authority>Israel: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The chances to achieve pregnancy after retrieving &gt;15 oocytes are not good, probably because
      of bad effect on the endometrium (uterine inner lining). Therefore, in most such cases the
      investigators prefer to freeze all embryos, and transfer in a thaw cycle. With the
      introduction of oocyte vitrification (very fast cooling)  technology, a new option emerged:
      to freeze un-fertilized eggs, to be fertilized and used later in a thaw cycle.

      The purpose of this study is to compare the outcome of these two approaches.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">March 2016</completion_date>
  <primary_completion_date type="Anticipated">January 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Fetal heart activity 1 month post embryo transfer</measure>
    <time_frame>1 month after embryo transfer</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>oocyte vitrification</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All retrieved mature oocytes will be vitrified.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>embryo freezing</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>All retrieved oocytes will be fertilized, and resulting embryos will be frozen.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>oocyte vitrification</intervention_name>
    <arm_group_label>oocyte vitrification</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>embryo freezing</intervention_name>
    <arm_group_label>embryo freezing</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  IVF patients

          -  ovulation trigger with Decapeptyl 0.2 mg because of ovarian hyper-response: E2 on
             trigger day .12,000 pmol/l and/or &gt;15 oocytes.

          -  Normal uterus

        Exclusion Criteria:

          -  &lt;20% fertilization rate
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Shahar Kol, Assistant professor</last_name>
    <phone>972-4-8543232</phone>
    <email>skol@rambam.health.gov.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>IVF Unit, Rambam medical Center</name>
      <address>
        <city>Haifa</city>
        <zip>31096</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shahar Kol, Assistant professor</last_name>
      <phone>972-4-8543232</phone>
      <email>skol@rambam.health.gov.il</email>
    </contact>
    <investigator>
      <last_name>Shahar Kol, assistant professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <reference>
    <citation>Devroey P, Polyzos NP, Blockeel C. An OHSS-Free Clinic by segmentation of IVF treatment. Hum Reprod. 2011 Oct;26(10):2593-7. doi: 10.1093/humrep/der251. Epub 2011 Aug 9. Review.</citation>
    <PMID>21828116</PMID>
  </reference>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 29, 2014</lastchanged_date>
  <firstreceived_date>December 30, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rambam Health Care Campus</investigator_affiliation>
    <investigator_full_name>Shahar Kol MD</investigator_full_name>
    <investigator_title>Director, IVF Unit</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
